PATENT CLAIM ANALYSIS

Application Number: 15924089
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["546", "143000"]

Abstract:
Provided are compounds that are inhibitors of both rho kinase and of a monoamine transporter (MAT) act to improve the disease state or condition. Further provided are compositions comprising the compounds. Further provided are methods for treating diseases or conditions, the methods comprising administering compounds according to the invention. One such disease may be glaucoma for which, among other beneficial effects, a marked reduction in intraocular pressure (IOP) may be achieved.

Claim (Index 7):
The pharmaceutical composition of  claim 6 , wherein the pharmaceutically acceptable carrier is saline buffered to a pH of about 5.5 to about 6.5.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 90.0
- Lexical Diversity: 1.49091
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12694965', '15445062', '13768594', '15627238', '15236625']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8431183795920362
- 35 USC 102 Novelty (BERT): 0.6474025071903605
- Combined Prediction Score: 0.8235467923518687
- Mean Citation Score: 351.941332
- Max Citation Score: 414.35083
- Similarity Product: 249.07753257448672

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test